and validation of cwlM and pbpB essentiality for viability and resistance to imipenem in

Jin Lee,Si-Yang Li,Dalin Rifat,Natalia Kurepina,Liang Chen,Barry N. Kreiswirth,Eric L. Nuermberger
DOI: https://doi.org/10.1101/2024.03.08.584109
2024-03-09
Abstract:lung infection is notoriously difficult to treat due, in part, to the intrinsic resistance of this pathogen to most marketed antibiotics. β-Lactams, namely imipenem and cefoxitin, are first-line drugs in combination regimens used to treat this infection; and there is growing interest in dual-β-lactam-based regimens. Better understanding of the molecular basis of β-lactam activity through study of the genetic determinants of β-lactam susceptibility and tolerance would enable more rational drug combinations and guide discovery of novel drug targets to complement β-lactams. We recently used an inducible CRISPR interference (CRISPRi) system to silence and and confirm their essentiality for growth and resistance to sub-MIC concentrations of imipenem. Here, we extend those findings to show that silencing either gene alone is bactericidal and augments the bactericidal activity of imipenem . Furthermore, using CRISPRi in a mouse model of lung infection for the first time, we confirm the essentiality of each gene for survival. These results validate and as essential genes and promising drug targets in this pathogen, including for potentiation of carbapenem activity. The results further establish CRISPRi as a powerful method for validating drug targets and studying gene-gene and gene-drug interactions and .
Microbiology
What problem does this paper attempt to address?